|Bid||21.17 x 900|
|Ask||0.00 x 1100|
|Day's range||23.58 - 24.41|
|52-week range||14.94 - 26.57|
|Beta (5Y monthly)||-0.45|
|PE ratio (TTM)||17.47|
|Earnings date||07 Aug 2020 - 12 Aug 2020|
|Forward dividend & yield||0.96 (3.96%)|
|Ex-dividend date||29 May 2020|
|1y target est||26.94|
Virtu Financial (VIRT) takes strategic actions to improve clients' access to electronic block liquidity via Interlisted Conditonal orders.
The iconic New York Stock Exchange floor is back open for business. Here is what New York Stock Exchange President Stacey Cunningham told Yahoo Finance.
Virtu Financial (NASDAQ: VIRT) delivered strong earnings and record revenue in the first quarter, another solid report for a stock that's gained about 50% this year. Virtu Financial is a high-frequency trading firm that quotes buy and sell prices for stocks, options, and various other securities and profits on the spread. Total revenue jumped 176% to $1 billion in the first quarter, compared to the same period in 2019.
Virtu Financial, Inc. (NASDAQ:VIRT) shareholders will have a reason to smile today, with the analysts making...
Virtu Financial (VIRT) delivered earnings and revenue surprises of 35.76% and 33.90%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Associated Banc-Corp (ASB) enters an agreement to sell Associated Benefits & Risk Consulting to USI Insurance Services for $265.755 million in cash.
Virtu Financial (VIRT) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Regional Management (RM) first-quarter 2020 results are expected to reflect a rise in interest income, partially offset by higher expenses.
Virtu Financial (VIRT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The Zacks Analyst Blog Highlights: Vertex Pharmaceuticals, Sprouts Farmers Market, The Hain Celestial, Virtu Financial and Pixelworks
Despite the coronavirus-induced economic disaster and stock market turmoil, a handful of Nasdaq stocks are set to beat earnings estimates.
The Zacks Analyst Blog Highlights: Clorox, Manning & Napier, Virtu Financial, PLDT and The Scotts Miracle-Gro